Abstract
Myelodysplastic syndromes are poorly understood at the biological level. In this perspective article, Drs. Galili, Qasim and Raza examine the role of defective ribosome biogenesis in the pathophysiology of myelodysplastic syndromes. See related paper on page 1453.